Генетическая информация для персонализации прогноза, профилактики и лечения некоторых социально значимых заболеваний

А.Т.Быков, А.А.Дюжиков, Т.Н.Маляренко Кубанский государственный медицинский университет, г. Краснодар, Ростовский центр кардиологии и сердечно-сосудистой хирургии, г. Ростов-на-Дону

2014 №1 | Лекции

Аннотация

Список литературы

Скачать полнотекстовую статью

Широко представлена генетическая информация для персонализации прогноза, профилактики и лечения некоторых социально значимых, в частности, сердечно-сосудистых заболеваний. Обсуждается современная проблема генетического риска, эффективность физических нагрузок, персонализированного питания, использования данных фармакогеномики.

Ключевые слова:

генетический риск заболеваний, персонализация прогноза, профилактики и фармакотерапии

Genetic information for personalization of prediction, prevention and treatment of some socially significant diseases

It is represented genetic information for the personalization of prediction, prevention and treatment some cardiovascular and other socially significant diseases, and discussed an efficacy of use of training exercise, personalized nutrition and treatment.

Keywords

genetic risk of some cardiovascular and other diseases, personalized medicine

1. Ardissino, D., Berzuini C., Merlini P.A., et al. Influence of 9p21.3 genetic variants on clinical and angiographic outcomes in early onset myocardial infarction // J. Am. Coll. Cardiol. 2011. Vol. 58. P. 426-434.
2. Booth, F.W., Lees S.J. Fundamental questions about genes, inactivity, and chronic diseases // Physiol. Genomics. 2007. Vol. 28. P. 146- 157.
3. Cirino, A.L., Ho C.Y. Genetic testing in cardiac disease: from bench to bedside // Cardiovasc. Med. 2006 Sept. Vol. 3. No. 9i. P. 462-464.
4. Dandona, S., Stewart A.F., Roberts R. Genomics in coronary artery disease: past, present and future // Can. J. Cardiol. 2010.Vol. 26 (suppl. A). P. 56A-59A.
5. Degoma, E.M., Rivera G., Lilly S.M., et al. Personalized vascular medicine: individualizing drug therapy // Vasc. Med. 2011. Vol. 16. P. 391- 404.
6. Forbes. Pharma & Healthcare. 2.06. 2013. Comments to article in New England J. Med. 7 Febr. 2013.
7. Gudbjartsson, S., Holm H., Gretarsdottir S., et al. A sequence variant in ZFHX3 on 16q22 aqssociated with atrial fibrillation and ischemic stroke // Nat. Genet. 2009. Vol.41. P. 876-878.
8. Helgadottir, A., Thorleifsson G., Manolescu A., et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction // Science. 2007. Vol. 316. P. 1491-1493.
9. Hernesniemi, J.A., Seppala I., Lyytikainen L.-P., et al. Genetic profiling using genome-wide significant coronary artery disease risk variants does not improve the prediction of subclinical atherosclerosis // PLoS ONE. January 2012. Vol. 7. Issue 1. e 28931. P.1-10.
10. Janssens, A.C.J., Aulchenko Y.S., Elefante S., et al. Predictive testing for complex diseases using multiple genes: fact or fiction? // Genet. Med. 2006. No. 8. P. 395-400.
11. Janssens, A.C.J., Moonesinghe R., Yang Q., et al. The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases // Genet. Med. 2007. No. 9. P. 528-535.
12. Janssens, A.C.J., van Duijn C.M. An epidemiological perspective on the future of direct-to-consumer personal genome testing // Investigative Genetics. 2010. Vol. 1. P. 1-10.
13. Janssens A.C.J., Van Duijn C.M. Genome-based prediction of common diseases: advances and prospects // Hum. Molec. Genetics. 2008. Vol. 17. Iss. R2. P. R166-R173.
14. Janssens, A.C.J., Wilde A.A.M., van Langen I.M. The sense and nonsense of direct-to-consumer genetic testing for cardiovascular disease // Neth. Heart J. 2011. Vol. 19. P. 85-88.
15. Jorgensen, J.T. A challenging drug development process in the era of personalized medicine // Drug discov. Today. 2011. Vol. 16. P. 891-897.
16. Kubo, M. Genetic risk factors of ischemic stroke identified by a genome-wide association study // Brain Nerve. 2008 Nov. Vol. 60. No. 11. P. 1339-1346.
17. Markus, H.S. Stroke genetics: prospects for personalized medicine // BMC Med. 2012. No. 10. P.113-121.
18. McPerson, R., Pertsemlidis A., Kavalar N., et al. A common allele on chromosome 9 associated with coronary heart disease // Science. Vol. 316. P. 1488-1491.
19. Nielsen, D.E., El-Sohemy A. A randomized trial of genetic information for personalized nutrition // Genes Nutr. 2012. No. 7. P. 559-566.
20. Ouzounian, M., Lee D.S., Gramolini A.O., et al. Predict, prevent and personalize: Genomic and proteomic approaches to cardiovascular medicine // Can. J. Cardiol. 2007. Vol. 23 (Suppl. A). P. 28A-33A.
21. Padang, R., Bagnall R., Semsarian Chr. Genetic basis of familial valvular heart disease // Circulation: Cardiovasc. Genetics. 2012. No.5. P. 569-580.
22. Roberts, R. Personalized medicine: a reality within this decade // J. Cardiovasc. Transl. Res. 2008. Mar. Vol. 1. No. 1. P. 11-16.
23. Roberts, R., Stewart A.F.R. 9p21 and the genetic revolution for coronary artery disease // Clin. Chemistry. 2012. Vol. 58. No. 1. P. 104-112.
24. Roberts, R., Stewart A.F.R. Genetics of CAD in the 21st century // Clin. Cardiol. 2012. Vol. 35. No. 9. P. 536-540.
25. Wray, N.R., Goddard M.E., Visscher P.M. Prediction of individual genetic risk to disease from genome-wide association studies // Genome Res. 2007. Vol. 17. P. 1520-1528.